Oct. 25-28, 2025

TCT 2025

Visit Booth 1348

Impella Heart Pump product demos, case insights and customer connections
Impella CP Impella CP

DanGer Shock RCT

New long-term data from the DanGer Shock RCT, published in the New England Journal of Medicine, validates the durability of original findings and confirms the survival benefit of Impella CP® heart pump increases year-over-year.1

 


 

Explore Additional Resources

On-Demand Courses

On-Demand Courses

Enroll in self-guided, on-demand learning helps you deepen your expertise in an effort to improve patient outcomes.

Upcoming Events

Upcoming Events

Explore our events page to participate in hands-on educational opportunities.

Education Library

Education Library

View clinical data and education articles.

References

  1. Møller J, et al.  Long Term Outcomes of the DanGer Shock Trial  N Engl J Med 2025.

IMP-7055

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].